Cargando…

Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pulsus Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729835/
http://dx.doi.org/10.1016/S0828-282X(22)01044-3
_version_ 1784845557327462400
collection PubMed
description
format Online
Article
Text
id pubmed-9729835
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pulsus Group
record_format MEDLINE/PubMed
spelling pubmed-97298352022-12-08 Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination Can J Cardiol Article Pulsus Group 2022-12 2022-12-08 /pmc/articles/PMC9729835/ http://dx.doi.org/10.1016/S0828-282X(22)01044-3 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
title Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
title_full Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
title_fullStr Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
title_full_unstemmed Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
title_short Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
title_sort canadian cardiovascular society receives $1.6 million to study myocarditis and/or pericarditis after mrna covid-19 vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729835/
http://dx.doi.org/10.1016/S0828-282X(22)01044-3